China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about $500 million. The Financial Times had reported in October that WuXi and WuXi ...

Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.

The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...

In a move to bolster global health cooperation, China has pledged its unwavering support for the World Health Organization ...

US pharmaceutical company Merck & Co said on Wednesday that its four-valent human papillomavirus vaccine has been approved for men aged 9 to 26 by China's top drug regulator. The vaccine that ...

Net profit likely fell 90 percent to 93 percent to between CNY86 million and CNY120 million (USD11.7 million to USD16.4 ...

The Chinese poultry lineage may have experienced more vaccine-driven selection compared ... there is a high risk of outbreaks, such as in China, Bangladesh, Egypt, Indonesia and Vietnam.

Professor Paul Hunter from the University of East Anglia notes that almost every child contracts HMPV by five years of age, with reinfections occurring throughout life. “HMPV typically causes ...

Philips CEO Roy Jakobs said he still expects subdued demand in China this year due to healthcare anti-corruption efforts by ...

Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond ...